SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001477932-19-004044
Filing Date
2019-07-12
Accepted
2019-07-12 10:48:06
Documents
3
Period of Report
2019-08-06
Effectiveness Date
2019-07-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A curr_def14a.htm DEF 14A 787107
2 curr_prer14aimg1.jpg GRAPHIC 1160
3 curr_prer14aimg2.jpg GRAPHIC 1160
  Complete submission text file 0001477932-19-004044.txt   791683
Mailing Address 1620 BEACON PLACE OXNARD CA 93033
Business Address 1620 BEACON PLACE OXNARD CA 93033 805-824-0410
Cure Pharmaceutical Holding Corp. (Filer) CIK: 0001643301 (see all company filings)

IRS No.: 371765151 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-55908 | Film No.: 19952271
SIC: 2673 Plastics, Foil & Coated Paper Bags